Herbage Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-05-2024
- Paid Up Capital ₹ 0.10 M
as on 27-05-2024
- Company Age 11 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -93.14%
(FY 2020)
- Profit 73.36%
(FY 2020)
- Ebitda 66.55%
(FY 2020)
- Net Worth -7.02%
(FY 2020)
- Total Assets -3.76%
(FY 2020)
About Herbage Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Jha and Kisan Sahoo serve as directors at the Company.
- CIN/LLPIN
U33111UP2013PTC056076
- Company No.
056076
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2013
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Mathura, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Herbage Pharmaceuticals Private Limited offer?
Herbage Pharmaceuticals Private Limited offers a wide range of products and services, including Medicinal Plant, Woodfordia Fruticosa, Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots, Herbal Powder, Manjistha Powder, Herbal Seeds, Ayurvedic Indian Herbs, Garden Plant, Ayurvedic Plant.
Who are the key members and board of directors at Herbage Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Jha  | Director | 26-Aug-2021 | Current |
| Kisan Sahoo | Director | 26-Aug-2021 | Current |
Financial Performance of Herbage Pharmaceuticals.
Herbage Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 93.14% decrease. The company also saw a substantial improvement in profitability, with a 73.36% increase in profit. The company's net worth dipped by a decrease of 7.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Herbage Pharmaceuticals?
In 2020, Herbage Pharmaceuticals had a promoter holding of 55.00% and a public holding of 45.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Atd Srammram Clean Energy Solutions Private LimitedActive 3 years 3 monthsKisan Sahoo is a mutual person
Atd Fintech Services Private LimitedActive 5 years 11 monthsDeepak Jha and Kisan Sahoo are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Herbage Pharmaceuticals?
Unlock and access historical data on people associated with Herbage Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Herbage Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Herbage Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
